Denham W, Regional Medical Advisor at Novo Nordisk

Denham W

Regional Medical Advisor at Novo Nordisk | United Kingdom

Profile last verified June 2026
Pharmaceuticals Verified Profile United Kingdom
Verified

Work Email

***@novonordisk.com

Last verified May 2026

Personal Email

***@googlemail.com

Personal • High Confidence

Phone Number

+44 ** **** *261

United Kingdom • Phone

Free account · No credit card · 5 profiles/month

Denham W Socials
Denham W Work Experience

Regional Medical Advisor at Novo Nordisk in April 2024 - Present

Lead Medical Science Liaison at Amarin Corporation in December 2021 - April 2024

Medical Science Liaison Manager at Boehringer Ingelheim in January 2016 - January 2022

See more See less

Medical Science Liaison Consultant at Novartis in March 2015 - November 2015

Regional Medical Advisor at Novo Nordisk A/S in July 2012 - December 2014

Scientific Advisor - Europe and Canada at Pfizer in February 2011 - June 2012

Medical Advisor - Europe & Canada at Pfizer in April 2010 - February 2011

Scientific advisor at sanofi-aventis in January 2006 - December 2010

Denham W Skills
Medical Affairs Diabetes Market Access Pharmaceutical Industry Oncology Clinical Development Rheumatology Pharmaceutical Sales Pharmacovigilance Endocrinology Cardiology Clinical Trials Therapeutic Areas Medical Writing Medicine Dermatology Health Economics Neurology
About Denham W’s Current Company
Novo Nordisk

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Discover more about Novo Nordisk
Denham W’s Colleagues
Tore Veum

Tore Veum

Norway

Global Director Frontline Excellence Rare Diseases, Novo Nordisk

Owner at Veum Consulting
(March 2015 – Present)

Naheel Korfiatis

Naheel Korfiatis

Dubai, United Arab Emirates

PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk

Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)

Karleen Rush

Karleen Rush

Raleigh-Durham-Chapel Hill Area

Medical Science Liaison, Diabetes & Renal

Wine Rep at ONEHOPE Wine
(June 2021 – Present)

Gaetano Gati

Gaetano Gati

Rome, Latium, Italy

Public Affairs Manager presso Novo Nordisk

Public Affairs Manager at Novo Nordisk
(May 2022 – Present)

Diego Bacelic

Diego Bacelic

Toronto, Ontario, Canada

Obesity Market Access | Novo Nordisk Canada

Consultant at Global Market Access Solutions
(May 2026 – May 2026)

Anne Preskou

Anne Preskou

Copenhagen, Capital Region of Denmark, Denmark

Associate Director – Novo Nordisk

Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)

Search similar profiles
Frequently asked questions about Denham W

What is Denham W email address?

Email Denham W at [email protected] and [email protected]. This email is the most updated Denham W's email found in 2026.

How to contact Denham W?

To contact Denham W send an email to [email protected] or [email protected]. (updated on January 01, 2026)

What company does Denham W work for?

Denham W works for Novo Nordisk.

What is Denham W's role at Novo Nordisk?

Denham W is Regional Medical Advisor

What industry does Denham W work in?

Denham W works in the Pharmaceuticals industry.

Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 1.4M users from 76% of Fortune 500 companies

Microsoft Tenstorrent Merck Rackspace WarnerMedia Societe Generale Yelp Google

The most accurate data ever

CCPA Compliant
GDPR Compliant
150M Personal Emails
200M Work Emails
100M Direct Dials
250M Professional Profiles
40M Company Profiles

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free